Skip to main content
Unit of study_

Commercialising MedTech and Pharma - PCOL5105

Year - 2020

This unit provides key business skills and related knowledge essential for the commercialisation of products in the medical device and pharmaceuticals sectors; from start-ups to large Pharma. The unit will provide students with a grounding in finance, human resources, market research and analysis, project management, risk management frameworks, regulatory and clinical strategy, freedom to operate and intellectual property. Students will learn how to develop a business case, based on market analysis, understand the process of capital fund raising and construct a development pathway for manufacturing and marketing of both medical devices and pharmaceutical products.

online lectures, podcasts, discussion boards, webinars, interactive media

online quizzes (20%), short answer questions/case studies (40%), written assignment(s) (40%)

Online resources, readings and other learning recourses will be provided or accessible via the Library


Faculty: Medicine and Health

Semester 2 Early

03 Aug 2020

Department/School: Pharmacology
Study Mode: Online
Census Date: 31 Aug 2020
Unit of study level: Postgraduate
Credit points: 6.0
EFTSL: 0.125
Available for study abroad and exchange: No
Faculty/department permission required? No
More details
Unit of Study coordinator: Dr Rania Salama and Dr Hui Xin Ong
HECS Band: 3
Courses that offer this unit

Non-award/non-degree study If you wish to undertake one or more units of study (subjects) for your own interest but not towards a degree, you may enrol in single units as a non-award student. Cross-institutional study If you are from another Australian tertiary institution you may be permitted to undertake cross-institutional study in one or more units of study at the University of Sydney.

To help you understand common terms that we use at the University, we offer an online glossary.